Interestingly, c-Myc, n-Myc and Hif-1α were the three top-ranked TFs with the highest number of predicted binding sites (Fig. 3a), in line with the notion that c-Myc overexpression in various cancers [53–55] positively modulates the expression of genes involved in glucose metabolism [56–59]. This evidence concerns the gene MYCN and cancer.